ESR1 and neoplasm: Four of the right cases with undetectable ESR1 mutation at progression were also PIK3CA mutated at baseline and all of these had PIK3CA mutation detected at the end of treatment, indicating the observed loss of ESR1 mutation was not an artifact of low tumor content.